Loading...

Long lasting response to second-line everolimus in kidney cancer

In the case presented here, everolimus was administered after first line therapy with sunitinib in a patient with metastatic renal cell carcinoma. The safety profile was excellent. The prolonged progression-free survival (PFS) obtained with everolimus in this case is of peculiar interest, as it is a...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Virtuoso, Antonella, Policastro, Tania, Izzo, Michela, Federico, Piera, Buonerba, Carlo, Rescigno, Pasquale, Di Lorenzo, Giuseppe
Format: Artigo
Sprog:Inglês
Udgivet: Baishideng Publishing Group Co., Limited 2013
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3845942/
https://ncbi.nlm.nih.gov/pubmed/24303493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v1.i5.166
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!